SciELO - Scientific Electronic Library Online

 
vol.23 número1Validación de un ELISA para la cuantificación de las impurezas proteicas de la cepa hospedera en el principio activo de la vacuna recombinante cubana contra la hepatitis B índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

  • Não possue artigos citadosCitado por SciELO

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Vaccimonitor

versão impressa ISSN 1025-028X

Resumo

PEREZ, Natacha et al. Structural Characterization of Granulocyte Colony Stimulating Factor, Hebervital. Vaccimonitor [online]. 2014, vol.23, n.1, pp.1-2. ISSN 1025-028X.

Granulocyte Colony Stimulating Factor (G-CSF) is member of haemopoietic proteins group used in medication. It is obtained by recombination technique since 2000 at the Center for Genetic Engineering and Biotechnology of Cuba, and it is commercialized as Hebervital. It is recommended for patients with malignant tumors, affected by febrile neutropenia, bone marrow suppressor treatment followed by bone marrow transplant, among others. It induces disorders in the biological activity of the mature neutrophils that could increase host defense in response to pathogens like bacterial and fungal infections. The objective of this project was to perform a specific analysis to determine G-CSF purity and characterization and to demonstrate its comparability with other commercial products. The sample bands pattern in SDS-PAGE, the area percentage and the chromatographic profiles under the curves, in reverse phase high performance liquid chromatographic were similar. The enzymatic digestion and separation by proteolysis of peptides generated reproduces peptide's maps of great similarity with Neupogen.

Palavras-chave : G-CSF; neutropenia; Hebervital; granulocyte colony stimulating factor; G-CSF; neutropenia; Hebervital.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons